Strategic analysis of the Varicose Veins Treatment market to understand the competitive outlook of the 2030 industry


varicose veins treatment

PORTLAND, OR, UNITED STATES, November 25, 2021 /EINPresswire.com/ – The growth of the global varicose vein treatment market is driven by the increasing incidence of varicose veins problems, increasing geriatric population, and technological advancements in varicose vein treatment devices. In addition, a growing awareness in emerging economies would provide lucrative opportunities for emerging market players in the near future. However, the shortage of qualified healthcare professionals and occasional product recalls are hampering the growth of the market.

Varicose veins treatment market, by procedure (injection sclerotherapy, endovenous ablation, surgical ligation and stripping), product (sclerotherapy injection, ablation devices and others) and end user (hospitals, clinics and outpatient centers): analysis of Global opportunities and industry forecast, 2019 – 2025. According to the report, the global varicose veins treatment market was worth $ 376.64 million in 2017 and is expected to reach $ 589.06 million by 2025, registering a CAGR by 5.7% during the forecast period, 2019-2025.

Explore report description @ https://www.alliedmarketresearch.com/varicose-vein-treatment-market

Covid-19 scenario:

– Even though Covid-19 is a viral infection, the radiological and clinical features that overlap with bacterial respiratory tract infection require oral antibiotics.

– Several virologists say that prescribing antibiotics to Covid-19 patients could create a more resistant virus, which would decrease the demand for antibiotics.

The injection sclerotherapy segment is expected to occupy the largest share in the near future.

By procedure, the injection sclerotherapy segment generated almost three-fifths of global revenue in 2017 and is expected to continue to dominate until 2025, due to the precise nature of its bottom line. However, the endovenous ablation segment is expected to grow at the highest CAGR of 6.9% during the forecast period, due to its ability to clear the collapsed vein through the body’s natural process.

Commercial use segment to dominate the global market until 2025

By product, ablation devices segment is poised to experience the highest growth from 2018 to 2025, a CAGR of 7.3%, as these devices are non-invasive and reduce recovery time. However, the sclerotherapy injections segment is expected to remain the dominant segment throughout the forecast period and occupy more than half of the global share.

Asia-Pacific will continue to dominate the global market

Regionally, Asia-Pacific is estimated to grow at the highest CAGR of 7.8% from 2018 to 2025, driven by growing consumer awareness, increasing geriatric population, and increasing adoption of technologies. advanced such as laser ablation and radiofrequency ablation.

For a purchase request to: https://www.alliedmarketresearch.com/purchase-enquiry/5184

Key market players

Major players analyzed in the report include Medtronic, Lumenis, Alma Lasers Ltd., Angiodynamics, Inc., Biolitec AG, BTG PLC, Energist Ltd., Sciton Inc., WONTECH Co., Ltd. and Syneron. They have adopted different strategies, including collaborations, joint ventures, partnerships, expansions, mergers and acquisitions and others, to gain a solid position in the industry.

Basic Avenue map | Access to the library | One year subscription |

Sign up for the Avenue subscription to access over 12,000 company profiles and over 2,000 niche market research reports at $ 699 per month per seat. For one year, the customer must purchase a minimum package of 2 places.

Avenue Library Subscription | Request a 14-day free trial before purchasing:https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information:https://www.alliedmarketresearch.com/library-access

Health Industry Trend Reports:

Global research into the hereditary cancer screening tests market by 2030

Global research on the immunohistochemistry market by 2030

Global IoT medical device market research by 2030

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting arm of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

Pawan Kumar, CEO of Allied Market Research, leads the organization towards delivering high quality data and information. We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. Each of the data presented in the reports we publish is taken from primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with knowledgeable professionals and analysts.

David Corréa
Allied analytics srl
+1 800-792-5285
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn



Source link

Previous Bracken Grand Jury Indictments
Next Rocking the Art World | Stuff.co.nz